A Replication Study for the Association of rs726252 in PAPPA2 with Developmental Dysplasia of the Hip in Chinese Han Population

Shi, Dongquan; Sun, Wei; Xu, Xingquan; Hao, Zheng; Dai, Jin; Xu, Zhihong; Chen, Dongyang; Teng, Huajian; Jiang, Qing

doi:https://doi.org/10.1155/2014/979520

BioMed Research International

On this page

Abstract Introduction Materials and Methods Discussion Acknowledgments References Copyright Related Articles

Research Article | Open Access

Volume 2014 | Article ID 979520 | https://doi.org/10.1155/2014/979520

A Replication Study for the Association of rs726252 in PAPPA2 with Developmental Dysplasia of the Hip in Chinese Han Population

Dongquan Shi,^1,2Wei Sun,^1,3Xingquan Xu,^1,2Zheng Hao,^1,4Jin Dai,^1,2Zhihong Xu,^1,2Dongyang Chen,^1,2Huajian Teng,²and Qing Jiang^1,2,3

Academic Editor: Wei Chiao Chang

Received14 Nov 2013

Revised21 Dec 2013

Accepted27 Dec 2013

Published03 Feb 2014

Abstract

Developmental dysplasia of the hip (DDH) is a common developmental hip disorder, which ranges from mild acetabulum malformation to irreducible hip dislocation. A previous study suggested a significant association of pregnancy-associated plasma protein-A2 (PAPPA2) with DDH susceptibility in Chinese Han population. But with the consideration of the sample size, the association was still debatable. To confirm the association of the reported single nucleotide polymorphism (SNP) in PAPPA2, rs726252 with DDH, we conducted a case-control study in a larger number of subjects. We genotyped rs726252 in 697 DDH subjects and 707 control subjects by TaqMan assay. The association between this SNP and DDH was evaluated statistically. No significant difference was found in any comparison of genotype distribution nor allele frequency between cases and controls. Our replication study indicated that the association between rs726252 and DDH in Chinese Han population was debatable. The association between PAPPA2 and DDH should be evaluated by additional studies.

1. Introduction

Developmental dysplasia of the hip (DDH) is a common developmental hip disorder, which ranges from mild acetabulum malformation to irreducible hip dislocation [1, 2]. DDH is a main cause of childhood disability and early onset hip osteoarthritis [3–5], and an epidemiologic study showed that DDH underlies up to 9% and 29% of all primary hip arthroplasty and those in people younger than 60 years, respectively [6]. DDH is affected by multiple factors including environmental and genetic factors. Family history of DDH, female gender, breech positioning at delivery, and large birth weight are risk factors of DDH [7]. In previous studies, we had detected associations between DDH and single nucleotide polymorphisms (SNPs) in GDF5, TBX4, and ASPN by case-control studies in Chinese Han population [8–10], and the association between DDH and GDF5 was also found in Caucasians [11].

Recently, a genome-wide linkage scan was conducted in a four-generation Chinese family of 25 members which includes 5 DDH patients. An association study based on the linkage scan was executed [12], and a SNP in pregnancy-associated plasma protein-A2 gene (PAPPA2), rs726252, was found to be associated with DDH. PAPPA2 encodes a novel metalloproteinase pregnancy-associated plasma protein-A2 which may play roles in fetal development [13–16]. In the comparison between 310 DDH patients and 487 control subjects, they detected significant differences of both genotype distribution and allele frequency of rs726252 ( and 0.0013, resp.). Significant differences of genotype distribution and allele frequency still existed after stratification by gender (female and 0.0079, male and 0.0035). The study suggested a significant association of PAPPA2 with DDH susceptibility in Chinese Han population. But with the consideration of the sample size, we thought the association between rs726252 and DDH was still debatable. To confirm the association of this SNP with DDH, we conducted a case-control study in a larger number of subjects.

2. Materials and Methods

2.1. Subjects

A total of 1404 subjects including 697 DDH patients and 707 healthy control subjects were enrolled in the study. The patients (594 females and 103 males) were consecutively recruited from the Center of Diagnosis and Treatment for DDH, Kang’ai Hospital, Nanjing, China, and the healthy control subjects (299 females and 408 males) were enrolled from the Physical Examination Center, Drum Tower Hospital Affiliated to Medical School of Nanjing University, China. The patients were diagnosed as unilateral or bilateral DDH by expert medical examination with radiographic evidence. The criteria of defining the severity of DDH were as previously described [8]. Patients with systemic syndrome were excluded from this study. The control subjects were identified by physical examination and detailed history, and they had no symptoms or histories of DDH. All subjects in the study were unrelated Han Chinese living in or around Nanjing, Southern China. No subjects dropped out during the process of the study. The study was approved by the ethical committee of Drum Tower Hospital Affiliated to Medical School of Nanjing University, and informed consent was obtained from patients and controls.

2.2. Genotyping

DNA was obtained from all the subjects from peripheral blood using the NucleoSpin Blood QuickPure Kit (Macherey-Nagel, German) according to the manufacturer’s instructions. The SNP rs726252 was genotyped using TaqMan assay on an ABI 7500 real-time polymerase chain reaction (PCR) instrument (Applied Biosystems 7500, ABI, Foster City, CA, USA). Genotyping was performed by laboratory personnel blinded to case status, and two authors independently reviewed the genotyping results, data entry, and statistical analyses.

2.3. Statistics

In this case-control study, we used standard chi-square analysis to compare the PAPPA2 genotype and allele distributions. Hardy-Weinberg equilibrium was also performed by chi-square test. The associations between PAPPA2 variants and DDH risk were evaluated by computing the odds ratios (ORs) and 95% confidence intervals (CIs) stratified by gender and severity. Meta-analysis of two studies was also conducted. All these statistical analyses were performed with SAS 9.1.3 software (SAS Institute, Cary, NC). The results were shown in Tables 1, 2, 3, and 4.

3. Result

The ages of DDH patients and controls (mean ± SD) were 23.2 ± 11.8 months (range, 2 to 83 months) and 56.2 ± 12.7 years (range, 34 to 76 years), respectively. The distributions of the alleles and genotypes for rs726252 are presented in Table 1. Distributions of genotypes in the DDH and control groups were conformed to Hardy-Weinberg equilibrium ( and 0.36, resp.). The minor allele frequency of rs726252 of controls in our study was 0.11, and it was closer to that reported in HapMap for Chinese Han populations (0.08) than the previous study [12]. We compared the genotype frequencies and allele frequencies between the patients and the controls; no significant difference was observed ( and 0.36, resp.). No significant difference was found in any comparison after stratification by gender and severity of DDH (Tables 2 and 3). We also compared allele frequency and genotype distribution in subjects between our study and the previous one. We found a significant difference of genotype distribution between our cases and Jia’s cases () and significant differences of allele frequency and genotype between our control subjects and Jia’s control subjects ( and 0.0002, resp.) (Table 4). In meta-analysis for the two studies, ORs of risk allele frequency (RAF) in case-control study are shown in Figure 1, ORs of RAF when stratified by gender are shown in Figures 2 and 3. Both in Figures 1 and 2, the allelic ORs are less than 1; however, in Figure 3, we found that OR in our study is different from Jia’s.

4. Discussion

In this study, a total of 1404 individuals were analyzed. For this SNP (rs726252), we did not detect any significant difference in genotype distribution or allele frequency between cases and controls, even after stratification by gender and severity of DDH. Our study indicated that rs726252 in PAPPA2 had no association with susceptibility to DDH in the Chinese Han population. Thus, our results do not support the previous results [12].

By comparison of allele frequency and genotype distribution in subjects between the two studies, there was no significant difference in comparison of allele frequency between our cases and Jia’s cases, but significant difference of genotype distribution was found between the case subjects in two studies. Significant differences were found in comparison of allele frequency and genotype distribution between control subjects in the two studies ( and 0.0002, resp.). We checked this SNP in HapMap database; the minor allele frequency was 0.08, and the minor allele frequency of control subjects of the two studies was 0.11 and 0.16. The minor allele frequency of this SNP of control subjects in our study was closer to that in Chinese population of HapMap database. The sample size in our study is twice larger than theirs, and it makes our data more reliable. So we inferred that there might be a sampling error in the previous study. Although the genetic difference between Southern China and North China is very small [17], it is also a potential influence factor for the different results.

There are also several limitations in the current study. First, due to low prevalence of DDH in males, the number of male subjects in our study was relatively limited. The sample size of hip instability and subluxation was also limited. We are continuously collecting both male and female subjects. Second, we only tested one SNP, rs726252 in the present study. We can only deny the association between this SNP and DDH. The association between this gene and DDH is still suspicious.

In conclusion, our replication study indicated that there was no association between rs726252 and DDH in Chinese Han population. The association between PAPPA2 and DDH was suspicious and it still needed further evaluation.

Conflict of Interests

The authors declare that there is no conflict of interests regarding the publication of this paper.

Authors’ Contribution

Wei Sun carried out the molecular genetic studies, performed the statistical analysis, and drafted the paper. Zheng Hao, Xingquan Xu, Jin Dai, Dongyang Chen, and Zhihong Xu participated in sample collection and DNA extraction. Huajian Teng participated in the design the study helped to carry out the molecular genetic studies. Qing Jiang and Dongquan Shi conceived of the study, and participated in its design and coordination, and helped to draft the paper. All authors read and approved the final paper. Dongquan Shi and Wei Sun contributed equally to this work.

Acknowledgments

This work was supported by China National Natural Science Funds for Youths (No. 81101338, No. 30901570) and China National Funds for Distinguished Young Scientists (No. 81125013).

References

M. K. D. Benson and A. M. Wainwright, “Developmental dysplasia of the hip,” Surgery, vol. 22, no. 1, pp. 5–9, 2004.
View at: Google Scholar
T. J. David, M. R. Parris, M. U. Poyner et al., “Reasons for late detection of hip dislocation in childhood,” The Lancet, vol. 2, no. 8342, pp. 147–149, 1983.
View at: Google Scholar
G. Hartofilakidis, T. Karachalios, and K. G. Stamos, “Epidemiology, demographics, and natural history of congenital hip disease in adults,” Orthopedics, vol. 23, no. 8, pp. 823–827, 2000.
View at: Google Scholar
C. Dezateux and K. Rosendahl, “Developmental dysplasia of the hip,” The Lancet, vol. 369, no. 9572, pp. 1541–1552, 2007.
View at: Publisher Site | Google Scholar
Y. Hasegawa, H. Iwata, M. Mizuno, E. Genda, S. Sato, and T. Miura, “The natural course of osteoarthritis of the hip due to subluxation or acetabular dysplasia,” Archives of Orthopaedic and Trauma Surgery, vol. 111, no. 4, pp. 187–191, 1992.
View at: Publisher Site | Google Scholar
O. Furnes, S. A. Lie, B. Espehaug, S. E. Vollset, L. B. Engesaeter, and L. I. Havelin, “Hip disease and the prognosis of total hip replacements. A review of 53,698 primary total hip replacements reported to the Norwegian Arthroplasty Register 1987–99,” Journal of Bone and Joint Surgery (British Volume), vol. 83, no. 4, pp. 579–586, 2001.
View at: Google Scholar
H. Patel, “Preventive health care, 2001 update: screening and management of developmental dysplasia of the hip in newborns,” Canadian Medical Association Journal, vol. 164, no. 12, pp. 1669–1677, 2001.
View at: Google Scholar
J. Dai, D. Shi, P. Zhu et al., “Association of a single nucleotide polymorphism in growth differentiate factor 5 with congenital dysplasia of the hip: a case-control study,” Arthritis Research & Therapy, vol. 10, no. 5, p. R126, 2008.
View at: Publisher Site | Google Scholar
K. Wang, D. Shi, P. Zhu et al., “Association of a single nucleotide polymorphism in Tbx4 with developmental dysplasia of the hip: a case-control study,” Osteoarthritis and Cartilage, vol. 18, no. 12, pp. 1592–1595, 2010.
View at: Publisher Site | Google Scholar
D. Shi, J. Dai, P. Zhu et al., “Association of the D repeat polymorphism in the ASPN gene with developmental dysplasia of the hip: a case-control study in Han Chinese,” Arthritis Research & Therapy, vol. 13, no. 1, p. R27, 2011.
View at: Publisher Site | Google Scholar
K. Rouault, V. Scotet, S. Autret et al., “Evidence of association between GDF5 polymorphisms and congenital dislocation of the hip in a Caucasian population,” Osteoarthritis and Cartilage, vol. 18, no. 9, pp. 1144–1149, 2010.
View at: Publisher Site | Google Scholar
J. Jia, L. Li, Q. Zhao et al., “Association of a single nucleotide polymorphism in pregnancy-associated plasma protein-A2 with developmental dysplasia of the hip: a case-control study,” Osteoarthritis and Cartilage, vol. 20, no. 1, pp. 60–63, 2012.
View at: Publisher Site | Google Scholar
M. T. Overgaard, H. B. Bold, L. S. Laursen, L. Sottrup-Jensen, C. A. Conover, and C. Oxvig, “Pregnancy-associated plasma protein-A2 (PAPP-A2), a novel insulin-like growth factor-binding protein-5 proteinase,” The Journal of Biological Chemistry, vol. 276, no. 24, pp. 21849–21853, 2001.
View at: Publisher Site | Google Scholar
X. Yan, R. C. Baxter, and S. M. Firth, “Involvement of pregnancy-associated plasma protein-A2 in insulin-like growth factor (IGF) binding protein-5 proteolysis during pregnancy: a potential mechanism for increasing IGF bioavailability,” The Journal of Clinical Endocrinology and Metabolism, vol. 95, no. 3, pp. 1412–1420, 2010.
View at: Publisher Site | Google Scholar
J. K. Christians, A. Hoeflich, and P. D. Keightley, “PAPPA2, an enzyme that cleaves an insulin-like growth-factor-binding protein, is a candidate gene for a quantitative trait locus affecting body size in mice,” Genetics, vol. 173, no. 3, pp. 1547–1553, 2006.
View at: Publisher Site | Google Scholar
J. Wang, Q. Qiu, M. Haider, M. Bell, A. Gruslin, and J. K. Christians, “Expression of pregnancy-associated plasma protein A2 during pregnancy in human and mouse,” The Journal of Endocrinology, vol. 202, no. 3, pp. 337–345, 2009.
View at: Publisher Site | Google Scholar
J. Chen, H. Zheng, J.-X. Bei et al., “Genetic structure of the Han Chinese population revealed by genome-wide SNP variation,” The American Journal of Human Genetics, vol. 85, no. 6, pp. 775–785, 2009.
View at: Publisher Site | Google Scholar

Copyright

Copyright © 2014 Dongquan Shi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PDF Download Citation

Download other formats

Order printed copies

Views

1439

Downloads

889

Citations